Skip to main content
. Author manuscript; available in PMC: 2013 Jul 12.
Published in final edited form as: Breast Cancer Res Treat. 2012 Mar 4;133(3):1125–1130. doi: 10.1007/s10549-012-1993-9

Table 3.

Joint ER and HER2 status of the tumors in the cohort

N ER+/HER2+ ER−/HER2+ ER+/HER2- ER−/HER2-
DCIS 11 3 5 3 -
IDC 32 17 3 10 2
Total 43 20 (47%) 8 (19%) 13 (30%) 2 (5%)